期刊文献+

肢端肥大症合并糖尿病或糖耐量减退经蝶窦手术的疗效 被引量:3

Acromegaly with diabetes mellitus or glucose intolerance: influence of transsphenoidal pituitary adenomas microsurgery for 77 cases
下载PDF
导出
摘要 目的总结经蝶窦垂体生长激素(GH)腺瘤切除术对肢端肥大症合并继发性糖尿病或糖耐量减退病人的疗效。方法回顾性分析77例采用经单鼻孔或口鼻蝶改良入路显微手术切除肿瘤治疗该类病人的临床资料。结果肿瘤全切除加次全切除率85.7%;内分泌治愈加缓解56例(72.7%);血糖达到糖尿病一般控制以上标准者67例(87.0%);术后死亡1例。结论经蝶窦手术切除肿瘤能够纠正肿瘤高GH分泌状态,可在术后1周左右使继发性糖尿病及糖耐量减退得到控制。应注意对病人的心功能进行评估与保护。 Objective To analyze the curative effect of transsphenoidal surgery for acromegaly with secondary diabetes mellitus (DM) and glucose intolerance (IGT). Methods 77 cases of acromegaly with DM and IGT were reviewed. Results The operative approach includes transnasal approach and sublabial approach. The rate of total excision and subtotal excision is 85.7%. The rate of cure and remission in endocrinology is 72.7% (56 cases), the control rate is 87.0% (67 cases), and the mortality is 1.3% (1 case). Conclusion While the high GH secretion was reduced by transsphenoidal pituitary adenomas microsurgery in acromegaly with DM or IGT, the hyperglycemia was relieved one week after operation. Moreover, the evaluation and protection of cardiovascular function is very important.
出处 《中国微侵袭神经外科杂志》 CAS 2005年第1期7-9,共3页 Chinese Journal of Minimally Invasive Neurosurgery
关键词 肢端肥大症 经蝶窦手术 糖尿病 葡萄糖耐量不良 acromegaly transsphenoidal microsurgery diabetes mellitus glucose intolerance
  • 相关文献

参考文献10

  • 1Etxabe J, Gaztambide S, Latorre P, et al. Acromegaly: an epidemiological study [J]. J Endocrinol Invest, 1993; 16(3):181-187.
  • 2曹一波 王松山.经鼻蝶入路垂体瘤切除术治疗继发性糖尿病[J].中国肿瘤临床与康复,2000,6(2):123-124.
  • 3史轶蘩.内分泌及代谢疾病学[M].北京:人民卫生出版社,1999:685-688.
  • 4Foss MC, Saad MJ, Paccola GM, et al. Peripheral glucose metabolism in acromegaly [J]. J Clin Endocrinol Metab,1991; 72(5): 1048-1053.
  • 5Kasayama S, Otsuki M, Takagi M, et al. Impaired b-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients[J]. Clin Endocrinol, 2000; 52(5): 549-555.
  • 6Ho KK, Jenkins AB, Furler SM, et al. Impact ofoctreotide, a long-acting somatostatin analogue, on glucose to lerance and insulin sensitivity in acromegaly [J]. Clin Endocrinol (Oxf),1992; 36(3): 271-279.
  • 7Rieger A, Rainov NG, Ebel H, et al. Factors predicting pituitary adenoma invasiveness in acromegalic patients [J].Neurosurg Rev, 1997; 20(3): 182-198.
  • 8Serri O, Beaubegard C, Hardy J. Long-term biochemical status and disease-related borbidity in 53 postoperative patients with acromegaly [J]. J Clin Endocrinol Metab, 2004;89(2): 658-661.
  • 9Colao A, Baldelli R, Marzullo P, et al. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy [J]. J Clin Endocrinol Metab, 2000; 85(1): 193-199.
  • 10Colao A, Ferone D, Marzullo P, et al. lymphocyte subset pattem in acromegaly [J]. J Endocrinol Invest, 2002; 25(2):125-128.

共引文献2

同被引文献22

  • 1中国肢端肥大症诊治指南[J].中国实用内科杂志,2013,33(7):519-524. 被引量:20
  • 2Etxabe J,Gaztambide S,Latorre P,et al. Acromegaly:an epidemiological study[J]. J Endocrinol Invest,1993,16(3):181-187.
  • 3Melmed S. Acromegaly[J]. N Engl J Med,1990,45(8):51-52.
  • 4Alberti KG,Zimmet PZ. Definition,diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med,1998(15):539-553.
  • 5Giustina A,Barkan A,Casanueva FF,et al. Criteria for cure of acromegaly:a consensus statement[J]. J Clin Endocrinol Metab,2000,85(2):526-529.
  • 6Couture E,Bongard V,Maiza JC,et al. Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide[J]. Pituitary,2012,15(4):518-525.
  • 7Colao A,Ferone D,Marzullo P,et al. Systemic complications of acromegaly:epidemiology,pathogenesis,and management[J]. Endocr Rev,2004,25(1):102-152.
  • 8Dreval AV,Trigolosova IV,Misnikova IV,et al. Prevalence of diabetes mellitus in patients with acromegaly.[J]. Endocrine Connections,2014,3(2):93-98.
  • 9Stelmachowska-banas′ M,Zdunowski P,Zgliczyński W. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms[J]. Endokrynol Pol,2009,60(1):20-24.
  • 10Sarkar S,Jacob KS,Pratheesh R,et al. Transsphenoidal surgery for acromegaly:predicting remission with early postoperative growth hormone assays[J]. Acta Neurochirurgica,2014,156(7):1379-1387.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部